Language selection

Search

Patent 1214776 Summary

Third-party information liability

Some of the information on this Web page has been provided by external sources. The Government of Canada is not responsible for the accuracy, reliability or currency of the information supplied by external sources. Users wishing to rely upon this information should consult directly with the source of the information. Content provided by external sources is not subject to official languages, privacy and accessibility requirements.

Claims and Abstract availability

Any discrepancies in the text and image of the Claims and Abstract are due to differing posting times. Text of the Claims and Abstract are posted:

  • At the time the application is open to public inspection;
  • At the time of issue of the patent (grant).
(12) Patent: (11) CA 1214776
(21) Application Number: 435457
(54) English Title: BASIC ACETANILIDES, A PROCESS FOR THEIR PREPARATION AND A PHARMACOLOGICAL COMPOSITION CONTAINING THESE ACETANILIDES
(54) French Title: ACETANILIDES, PROCEDE DE PREPARATION ET COMPOSE PHARMACOLOGIQUE LES CONTENANT
Status: Expired
Bibliographic Data
(52) Canadian Patent Classification (CPC):
  • 260/553.2
  • 260/325.4
  • 260/293.7
  • 260/555.9
(51) International Patent Classification (IPC):
  • C07D 295/14 (2006.01)
  • C07D 295/15 (2006.01)
(72) Inventors :
  • RUDINGER, EDITH (Switzerland)
  • PERLIA, XAVIER (Switzerland)
(73) Owners :
  • PHARMATON S.A. (Not Available)
(71) Applicants :
(74) Agent: MARKS & CLERK
(74) Associate agent:
(45) Issued: 1986-12-02
(22) Filed Date: 1983-08-26
Availability of licence: N/A
(25) Language of filing: English

Patent Cooperation Treaty (PCT): No

(30) Application Priority Data:
Application No. Country/Territory Date
5116/82-8 Switzerland 1982-08-27

Abstracts

English Abstract



ABSTRACT OF THE DISCLOSURE

The present invention provides basic acetanilides
of the formula III

III
Image


wherein R1 is hydrogen or lower alkyl, and R4 is halogen,
lower alkoxy, nitro, amino or propionyl or trihalomethyl,
and R5 is a basic group selected from di lower alkyl amino,
lower cyclo alkyl amino; or a 6-membered heterocyclic group
having at least one nitrogen atom in the ring. A process
for preparing these acetanilides is described. The com-
pounds are useful as local anaesthesia and antiarrhythmics.


Claims

Note: Claims are shown in the official language in which they were submitted.



THE EMBODIMENTS OF THE INVENTION IN WHICH AN
EXCLUSIVE PROPERTY OR PRIVILEGE IS CLAIMED ARE DEFINED AS
FOLLOWS:


1. A process for preparing a basic acetanilide of
the formula III

III
Image


wherein R1 is hydrogen or lower alkyl, and R4 is halogen,
lower alkoxy, nitro, amino or propionyl or trihalomethyl,
and R5 is a basic group selected from di lower alkyl amino,
lower cyclo alkyl amino; or a 6-membered heterocyclic group
having at least one nitrogen atom in the ring which comprises
reacting a compound of formula IV.


12




Image IV



wherein R1 and R4 are defined above and Hal is a halogen
atom in an inert solvent at elevated temperature with an
amine delivering the group R5 as defined above, and, when
required, converting the obtained compound into a pharma-
cologically useful salt.

2. A process according to claim 1, in which the
compound of formula IV is prepared by reacting an aniline of
the formula I


Image I


wherein R1 and R4 are defined above under cooling or at room
temperature in a solvent and in the presence of a base with
a halogen compound of formula II

X-CO-CH2-Hal (II)

wherein X is a hydroxyl group, an ester group, a halide, an
amide group or an anhydride group and Hal is a halogen atom.

3. A process of claim 2, in which the compound of
formula II is an acid chloride or acid bromide.


13

4. A basic acetanilide of formula III

III
Image


wherein R1 is hydrogen or lower alkyl, and R4 is halogen,
lower alkoxy, nitro, amino, propionyl or trihalomethyl, and R5 in
a basic group selected from di lower alkyl amino, lower cyclo
alkyl amino; or a 6-membered heterocyclic group having at
least one nitrogen atom in the ring or a pharmacologically
useful salt thereof whenever prepared or produced by the pro-
cess claimed in claim 1, 2 or 3.

5. A process according to claim 1, in which R1 is
hydrogen or methyl, R4 is chlorine, bromine, trihalomethyl,
ethoxy, nitro, amino or propionyl and R5 is diethylamino,
piperidino, pyrrolidino, cyclopropylamino or cyclopentylamino.

6. A process according to claim 5, in which the
free acid is converted into a salt selected from the hydro-
chlorides, hydrobromides, fumarates, maleates, hydrogen
fumarates and hydrogen maleates.

7. A basic acetanilides of formula III given in
claim 1 or a pharmacologically useful salt thereof where R1,
R4 and R5 are as in claim 5 whenever prepared or produced by
the process claimed in claim 5 or an obvious chemical equivalent
thereof.

8. A salt of a basic acetanilide of formula III
given in claim 1, where R1, R4 and R5 are as in claim 5 when-
ever prepared or produced by the process claimed in claim 6 or
an obvious chemical equivalent thereof.

9. A process according to claim 1 which comprises
refluxing 2-chloro-2'-ethoxy-6'-methyl-acetanilide in ben-


14

zene and with diethylamine.

10. 2-diethylamino-2'-ethoxy-6'-methyl-acetanilide
whenever prepared or produced by the process claimed in claim
9 or an obvious chemical equivalent thereof.

11. A process according to claim 1 which comprises
refluxing 2-chloro-2'-ethoxy-6'lmethyl-acetanilide in ben-
zene and with piperidine.

12. 2-piperidino-2'-ethoxy-6'-methyl-acetanilide
whenever prepared or produced by the process claimed in claim
11 or an obvious chemical equivalent thereof.

13. A process according to claim 1 which comprises
refluxing 2-chloro-2'-ethoxy-6'-methyl-acetanilide in ben-
zene and with pyrrolidine.

14. 2-pyrrolidono-2'-ethoxy-6'-methylacetanilide
whenever prepared or produced by the process claimed in claim
13 or an obvious chemical equivalent thereof.

15. A process according to claim 1 which comprises
refluxing 2-chloro-2'-methyl-6'-nitro-acetanilide in benzene
and with diethylamine.

16. 2-diethylamino-2'-methyl-6'-nitro-acetanilide
whenever prepared or produced by the process claimed in claim
15 or an obvious chemical equivalent thereof.

17. A process according to claim 1 which comprises
refluxing 2-chloro-2'-methyl-6'-nitro-acetanilide in benzene
and with piperidine.

18. 2-piperidino-2'-methyl-6'-nitro-acetanilide
whenever prepared or produced by the process claimed in claim
17 or an obvious chemical equivalent thereof.



19. A process according to claim 1 which comprises
refluxing 2-chloro-2'-trifluoromethyl-acetanilide in benzene
and with diethylamine.

20. 2-diethylamino-2'-trifluoromethyl-acetanilide
whenever prepared or produced by the process claimed in claim
19 or an obvious chemical equivalent thereof.

21. A process according to claim 1 which comprises
refluxing 2-chloro-2'-trifluoromethyl-acetanilide in benzene
and with pyrrolidine.

22. 2-pyrrolidine-2'-trifluoromethyl-acetanilide
whenever prepared or produced by the process claimed in claim
21 or an obvious chemical equivalent thereof.

23. A process according to claim 1 which comprises
refluxing 2-chloro-2'-propionyl-acetanilide in benzene and
with pyrrolidine.

24. 2-pyrrolidino-2'-propionyl-acetanilide whenever
prepared or produced by the process claimed in claim 23 or an
obvious chemical equivalent thereof.

25. A process according to claim 1 which comprises
refluxing 2-chloro-2'-methyl-6'-propionyl-acetanilide in ben-
zene and with pyrrolidine.

26. 2-pyrrolidino-2'-methyl-6'-propionyl-acetanilide
whenever prepared or produced by the process claimed in claim
25 or an obvious chemical equivalent thereof.

27. A process according to claim 1 which comprises
refluxing 2-chloro-2'-chloro-6'-methyl-acetanilide in absolute
toluene with cyclopentylamine.


16

28. 2-cyclopentylamino-2'-chloro-6'-methyl-acetanilide
whenever prepared or produced by the process claimed in claim
27 or an obvious chemical equivalent thereof.

29. A process according to claim 1 which comprises
heating a mixture of 2-chloro-2'-chloro-6'-methyl-acetanilide
and cyclopropylamine in a autoclave at 100°C.

30. 2-cyclopropylamino-2'-chloro-6'-methyl-acetanilide
whenever prepared or produced by the process claimed in claim
29 or an obvious chemical equivalent thereof.


17

Description

Note: Descriptions are shown in the official language in which they were submitted.


77~

The present inverltion rela-tes to nove~ hasic ace-
tani.li.des, to a process for their preparation and to a phar-
maceutica1 composition con-taining these novel acetanilides.

The present invention provides novel compounds which
e.g. may be used as local anaesthesia and antiarrhythmic
active agents, and which show a lower toxicity and an improved
effectiveness over the compounds known in the ar-t.

The presen-t invention also provides processes for
preparing the novel compounds, which are easy to carry out
and which are economical.

According to the present invention there are pro-
vided basic acetanilides having the formula III


/ Rl

/j ~ I]:I
/ ----Nll-C~-C112-~5
o
R~




"~

~214776


WhC`I-eill 1~1 is l~ydrogerl or a lower allcyl ~1roup, a1~d 1~4 is
1~alo9e1l, a lower alkoxy, a nitro, amino, propiony1 or trl-
halomethyl, particularly a trifluoromethyl group and R5 is
a basic group selected from di lower alkyl amino, lower cyclo
alkyl amino, or a 6-membered heterocyclic group having at
least one nitrogen atom in the ring and their pharmacologi-
cally useful salts.

The process of the present invention Eor preparing
thc 1~ovel basic acetanilides of the formula III




~_

- ~214776


Nl-l -C -C~ R5 :[ I I

~

wherein R~ 4 and R5 are defined above, and their pharma-
cologically useful salts, is characterized in that an
lQ aniline of the formula I

_~ 1
/~ \ ~ I
N1~2
1~ ~'~< ' ,.
R4
wherein Rl and R4 are defined above, is reacted under cool-
ing or at room temperature in a solvent and in the presence
of a base with a halogen compound of formula II
X-CO-CH2-Hal II

wherein X is a hydroxyl group, an ester group, a halide, an
amide group or an anhydride group, and Hal is a halogen atom
to yield a compound of formula IV

--/ 1
~ l-l-co-c~l2-llal IV


wherein Rl, R4 and Hal are defined above, and that then
these compounds are reacted in an inert solvent at elevated
temperature with an amine delivering the group R5, and that
the obtained compounds may be transformed into their phar-


g - 3 -

77~

macoloqically ~Iseful salts.

The interrnediates of formula IV are prepared in
such a way that halogen fatty acids or other suitable
derivatives, such as esters, halides (e.g. acid chloride or
bromide), amides or anhydrides, are contacted with an
aniline under cooling or at room temperature in a solvent,
e.~. acetone, acetic acid, acetic acid ethylester, chloro-
form, in the presence of a base, such as sodiu~ carbonate,
lo potassium carbonate, sodium bicarbonate or potassium bi-
carbonate, sodium acetate, or in an aqueous sodium acetate
buffer. The halogen acetanilides of the general formula IV
are reacted with an amine in an inert solvent, preferably
benzene, at an elevated temperature.
The acetanilides of the general formula III may
also be prepared without isolation of the intermediate of
the formula IV, in that after the halogen alkanoylization
the corresponding amine is added to the reaction mixture in
a higher boiling inert solvent, e.g. toluene or xylene,
followed by heating this mixture.

The compounds of the general formula III, wherein
R4 is amino, may be prepared from the corresponding ace-
tanilides of the formula III, wherein R4 is nitro, by reduc-
tion.

The acetanilides of formula III, wherein R4 is
halogen, may be prepared either from the corresponding
anilines, as described above, or from the acetanilides,
wherein R4 is amino, with the Sandmeyer reaction.

The process of this invention may also be effected
in the presence of catalysts. A person skilled in the art
may easily determine the suitable reaction tempe~ratules and
reaction times~ Usually one works at standard pressur.,

- 4 -

776

whereby also excess pressure and under pressure (vacuum) are
not excluded.

The administration of the novel compounds of
formula III according to this invention is realized in a
conventional way, as this is known in the prior art for the
known compounds.

The preferred embodiments are illustrated in the
set of Examples, wherein also some nove~ starting materials
and intermediates are described and where the temperatures
are in C

A. With isolation of the intermediate of the
~ormula ~V

Example 1

To a mixture of 53 g (0.35 mol) 2-ethoxy-6-
methyl-aniline in 525 ml absolute acetone and 70 g sodium
bicarbonate are added drop by drop under cooling with ice
during one hour 46 g (0.4 mol) chloroacetyl chloride, and
then this mixture is stirred for one hour at room tempera-
ture. The inorganic salt is filtered with suction and
washed with acetone. The filtrate is evaporated in the
vacuum of a water jet pump, to the residue water is added,
and the precipitated crystals of 2-chloro-2'-ethoxy-6'-
methyl-acetanilides, mp. 148-149, are filtered with
suction.
Example 2

As described in Example 1, 2-chloro-2'-methyl-6'-
nitro-acetanilide is obtained, mp 140-141.5 when 2-methyl-
6-nitro-aniline is used instead of 2-ethoxy-6-methyl-ani-
line.

776

Alnillat.io

.Ex am~ :1. e
_ _

To 10.25 ~ (0.0~5 mol) 2-chloro-2'-ethoxy-6'-
methyl-acetarlilide in 10 ml benzene are added to 10 g (0.136
mol) diethylamine and this mixture is refluxed for 6 hours.
After cooling the precipitated die-thylamine hydrochloride is
filtered with suction, washed with benzene! and the filtrate
is evaporated in the vacuum of the water jet pump. To the
residue is added water and ether, the base is extracted from
the ether layer with 5% hydrochloric acid, the aqueous aci-
dic solution is rendered alkaline,and extracted with ether.
After drying and evaporation the ether the resiude is dis-

solved in ethanol, and under cooling, ethereal hydrochloricacid is added drop by drop, and the hydrochloride of 2-
diethyl amino-2'-ethoxy-6'-methyl-acetanilide, mp. 107-109 ,
is obtained.

Example 2

As described in Example 1, 2-piperidino-2~-ethoxy-
6'-methyl-acetanilide, mp. 79-80, is obtained, and the base
is reacted to the hydrochloride, mp. 192-193, when piperi-
dine is used instead of diethylamine.

Example 3

When pyrrolidine is used instead of diethylamine,
as described in Example 1, 2-pvrro]idino-2'-ethoxy-6'-
methyl-acetanilide, mp. 60.5-62 is obtained, which is
reacted to the hydrochloride, mp~. 180~181.5.

xample
As described in Example 1, 2-diethyla~ o-2'-


.~ \ 6 ~

776

methyl-6'-llitro-acetanilide, mp. 60~-61, is obtained from
2-chloro-2'-methyl-6'-nitro-acetanilide and diethylamine, as
well as its hydrochloride, mp. 166-168 .

Example 5

When piperidine is used instead of diethylamine~
as described in Example 4, 2-piperidino-2'-methyl-6'-nitro-
acetanilide, mp. 72-73, and its hydrochloride, mp. 192-
194, is obtained.

Example 6

As described in Example 1, the hydrochloride of
2-diethylamino-2'-trifluoromethyl-acetanilide, mp. 160.1,
is prepared, when 2-chloro-2'-trifluoromethyl-acetanilide
and diethylamine is used.




Example 7
When pyrrolidine is used instead of diethylamine,
as described in Example 6, the hydrochloride of 2-pyrroli-
dino-2'-trifluoromethyl-acetanilide, mp. 229.4, is obtai-
ned.

Example 8

As described in Example 1, the hydrochloride of
2-pyrrolidino-2'-propionyl-acetanilide is prepared, when
2-chloro-2'-propionyl-acetanilide and pyrrolidine are used.

Example 9

As described in Example 1, the hydrocllloride of 2-
35 pyrrolidino-2'-methyl-6'-propionyl-acetanilide, mp. 192.6,
is prepared when 2-chloro-2'-methyl-6'-propionyl-acetallilide

~r
f~ - 7 -

1~:14776

and pyrrolidine are used.

Tlle 2-methyl-6-propionyl-aniline, which is used as
startin~ material, is prepared as follows from 2-amino-3-
methyl-benzonitrile:

From 6.3 g (0.26 mol) magnesium and 25.5 g ethyl-
bromide in 130 ml absolute ether the ethyl magnesium-bromide
is prepared which is heated for 30 minutes on the water
bath. A solution of 6.65 (0.05 mol) 2-amino-3-methyl-
benzonitrile in 100 ml absolute ether is then added slowly
drop by drop, and the mixture is refluxed under stirring for
15 hours. After cooling the mixture is poured on 110 g ice
and the solution of 15.6 g ammonium-chloride in 67 ml water
is added. The ether layer is separated, and the aqueous
layer is extracted wi-th ether. From the combined ether
layer the ether is distilled off, and the residue is re-
fluxed with 9.5 ml water and 11.2 m] concentrated hydro-
chloric acid for 30 minutes. After cooling the mixture is
extracted with ether, the aqueous layer is rendered alkaline
and extra~cted with ether. After drying and evaporating the
ether the 2-methyl-6-propionyl-aniline is obtained, which
was characterized as hydrochloride, mp. 191.2.

Example 10
.

To 10.9 g (0~.05 mol) 2-chloro-2'-chloro-6'-
methyl-ace-tanilide in 30 ml absolute toluene are added 12.75
g (0.15~mol) cyclopentylamine in 50 ml toluene, and this
mixture is refluxed for 6 hours. After cooling the pre-
cipitated cyclopentylamine-hydrochloride is filtered with
suction, the filtrate is evaporated and to the residue is
added water and ether. The ether is e~tracted with 5~
hydrochloric acid solution, wherefrom the hydrochloride of
2-cyclopentylamine-2'-chloro-6'-methyl-acetanilide crys-
tallizes, mp. 20~.7.


-- 8
\

` ~214776

From 1 g of the hydrochloride the base was pre-
pared, mp. 76.8 .

Example 11




When cyclopropylamine in benzene is added to 2-
chloro-2'-chloro-6'-methyl-acetanilide and when this mixture
is heated in an autoclave having a glass insertion for 10
hours at a temperature of 100, and when after cooling the
prescription of Example 1 is followed, then the hydrochlo-
ride of 2-cyclopropylamine-2'-chloro-6'-methyl-acetanilide,
mp. 257, is obtainéd.

B. Without isolation of the intermediate of
formula IV

Example 1

To 18.6 g (0.1 mol) 2-bromo-6-methyl-aniline in
150 ml absolute acetone and 20 g sodium bicarbonate are
added drop by drop under cooling with ice during one hour 12
g (0.11 mol) chloroacetyl chloride and then this mixture is
stirred at room temperature for 30 minutes. To the mixture
are added 22 g (0.3 mol) diethylamine in 50 ml toluene, and
this mixture is refluxed for 6 hours. The further treatment
is the same as described in section A in Example 1.

The hydrochloride of the 2-diethylamino-2'-bromo-
6'-methyl-acetanilide, mp. 172-174, is obtained.
a) The same 2-diethylamino-2'-bromo-6'-methyl-
acetanilide can be prepared according to the Sandmeyer
reaction from 2-diethylamino-2'-amino-6'-methyl-acetanilide
as follows:
11.75 g (0.05 mol) 2-diethylamino-2'-amino-6`-


~'


~214776

methyl-acetanilide in 30 ml 48go hydrobromic acid are cooled
in an ice bath, and at a temperature of -5 this mixture is
diazotized with 3.45 g sodium nitrite in 20 ml water during
30 minu~es (iodo-starch paper test) and then this mixture is
stirred for 40 minutes at a temperature of -5. This sus-
pension is added slowly to a mixture having a temperature of
70 of 4 g CuBr in 20 ml 48% hydrobromic acid, and this
mixture is stirred for 2 hours at this temperature. After
cooling this mixture is extracted with ether, the acidic
solution is rendered alkaline and ex-tracted with ether.
After drying and evaporating the ether the residue is dis-
solved in ethanol and transformed into the hydrochloride
with ethereal hydrochloric acid, which is identical with the
product, mp. 172-174, described in Example 1.
Reduction of the 2-diethylamino- and 2-piperidino-
2'-methyl-6'nitro-acetanilide.

Example 1
a) To 25 g (0.094 mol) 2-diethylamino-2'-methyl-

6'-nitro-acetanilide in 500 ml concentrated hydrochloric
acid are added under stirring during one hour 100 g tin
(II)-chl~oride. The mixture is heated for 30 minutes on a
boiling water bath, after cooling with ice this mixture is
rendered alkaline with 35% sodium hydroxide solution,
followed by an extraction with ether. After washing, drying
and evaporating the ether the 2-diethylamino-2'-amino-6'-
methyl-acetanilide, mp. 105-106.5, is obtained, which is
transformed into its dihydrochloride, mp. 182-184, with
ethereal hydr,ochloric acid.

b) The same 2-diethylamino-2'-amino-6'-methyl-
acetanilide is also obtained as follows:

To a mixture of 300 ml Pd/C in 60 ml water under


~-- 10 --

1~14776

nitrogen are added 4.8 c; sodium borohydride in 90 ml water.
Thell the solutioll of 15.9 g~(0.06 mol) 2-diethylamirlo-2'-
methyl-6'-llitro-acetallilide in 150 ml Methanol is added drop
by drop during 30 minutes, and this mixture is filtra-ted,
the filtrate is evaporated in -the vacuum of a water jet
pump, water is added and the precipitated crystals are
filtered with suction. Mp. 105-106.5 .

Example 2
1~
As described in Example l b), 2-piperidino-2'-
amino-6'-methylacetanilide, mp. 169-170, is prepared with
-the difference, that the mixture is heated before the
filtration, because -the product is lit-tle soluble in cold
methanol. The base is dissolved in ethanol and transfor-
med with an etheric hydrochloric acid into -the dihydro-
chloride. MP. 25g-260C.




~ -- 11 --

Representative Drawing

Sorry, the representative drawing for patent document number 1214776 was not found.

Administrative Status

For a clearer understanding of the status of the application/patent presented on this page, the site Disclaimer , as well as the definitions for Patent , Administrative Status , Maintenance Fee  and Payment History  should be consulted.

Administrative Status

Title Date
Forecasted Issue Date 1986-12-02
(22) Filed 1983-08-26
(45) Issued 1986-12-02
Expired 2003-12-02

Abandonment History

There is no abandonment history.

Payment History

Fee Type Anniversary Year Due Date Amount Paid Paid Date
Application Fee $0.00 1983-08-26
Owners on Record

Note: Records showing the ownership history in alphabetical order.

Current Owners on Record
PHARMATON S.A.
Past Owners on Record
None
Past Owners that do not appear in the "Owners on Record" listing will appear in other documentation within the application.
Documents

To view selected files, please enter reCAPTCHA code :



To view images, click a link in the Document Description column. To download the documents, select one or more checkboxes in the first column and then click the "Download Selected in PDF format (Zip Archive)" or the "Download Selected as Single PDF" button.

List of published and non-published patent-specific documents on the CPD .

If you have any difficulty accessing content, you can call the Client Service Centre at 1-866-997-1936 or send them an e-mail at CIPO Client Service Centre.


Document
Description 
Date
(yyyy-mm-dd) 
Number of pages   Size of Image (KB) 
Drawings 1993-07-19 1 7
Claims 1993-07-19 6 155
Abstract 1993-07-19 1 16
Cover Page 1993-07-19 1 18
Description 1993-07-19 11 321